Chenodeoxycholic acid glycine conjugate

Common Name

Chenodeoxycholic acid glycine conjugate Description

Chenodeoxycholic acid glycine conjugate is an acyl glycine and a bile acid-glycine conugate. It is a secondary bile acid produced by the action of enzymes existing in the microbial flora of the colonic environment. In hepatocytes, both primary and secondary bile acids undergo amino acid conjugation at the C-24 carboxylic acid on the side chain, and almost all bile acids in the bile duct therefore exist in a glycine conjugated form (PMID:16949895 ). This compound usually exists as the sodium salt and acts as a detergent to solubilize fats for absorption and is itself absorbed. It is a cholagogue and choleretic. Structure

Synonyms

Value Source (23R)-HydroxychenodeoxycholylglycineHMDB 12-DeoxycholylglycineHMDB 12-DesoxycholylglycineHMDB 3a,7a-Dihydroxy-N-(carboxymethyl)-5b-cholan-24-amideHMDB ChenodeoxycholylglycineHMDB Glycine chenodeoxycholateHMDB GlycochenodeoxycholateHMDB Glycochenodeoxycholic acidHMDB GlycylchenodeoxycholateHMDB Glycylchenodeoxycholic acidHMDB N-(3a,7a-Dihydroxy-5b-cholan-24-oyl)-glycineHMDB N-(Carboxymethyl)-3a,7a-dihydroxy-5b-cholan-24-amideHMDB Acid, glycochenodeoxycholicMeSH Chenodeoxycholate, glycineMeSH

Chemical Formlia

C26H43NO5 Average Molecliar Weight

449.6233 Monoisotopic Molecliar Weight

449.314123491 IUPAC Name

2-[(4R)-4-[(2S,5R,7S,9R,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanamido]acetic acid Traditional Name

[(4R)-4-[(2S,5R,7S,9R,14R,15R)-5,9-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanamido]acetic acid CAS Registry Number

640-79-9 SMILES

[H][C@@]12C[C@H](O)CC[C@]1(C)C1CC[C@]3(C)[C@H](CCC3C1[C@H](O)C2)[C@H](C)CCC(=O)NCC(O)=O

InChI Identifier

InChI=1S/C26H43NO5/c1-15(4-7-22(30)27-14-23(31)32)18-5-6-19-24-20(9-11-26(18,19)3)25(2)10-8-17(28)12-16(25)13-21(24)29/h15-21,24,28-29H,4-14H2,1-3H3,(H,27,30)(H,31,32)/t15-,16+,17-,18-,19?,20?,21-,24?,25+,26-/m1/s1

InChI Key

GHCZAUBVMUEKKP-AHBZRTSYSA-N Chemical Taxonomy Classification

Not classified Ontology Status

Detected and Quantified Origin

  • Endogenous
  • Food
  • Microbial
  • Biofunction

  • Cell signaling
  • Fuel and energy storage
  • Fuel or energy source
  • Membrane integrity/stability
  • Application

  • Nutrients
  • Stabilizers
  • Surfactants and Emlisifiers
  • Cellliar locations

  • Extracellliar
  • Physical Properties State

    Solid Experimental Properties

    Property Value Reference Melting PointNot AvailableNot Available Boiling PointNot AvailableNot Available Water Solubility0.00315 mg/mLNot Available LogP2.12RODA,A ET AL. (1990)

    Predicted Properties

    Property Value Source Water Solubility0.0079 mg/mLALOGPS logP2.4ALOGPS logP2.61ChemAxon logS-4.8ALOGPS pKa (Strongest Acidic)3.77ChemAxon pKa (Strongest Basic)-0.29ChemAxon Physiological Charge-1ChemAxon Hydrogen Acceptor Count5ChemAxon Hydrogen Donor Count4ChemAxon Polar Surface Area106.86 Å2ChemAxon Rotatable Bond Count6ChemAxon Refractivity122.08 m3·mol-1ChemAxon Polarizability52.04 Å3ChemAxon Number of Rings4ChemAxon Bioavailability1ChemAxon Rlie of FiveYesChemAxon Ghose FilterYesChemAxon Vebers RlieYesChemAxon MDDR-like RlieYesChemAxon

    Spectra Spectra

    Spectrum Type Description Splash Key Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, PositiveNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 10V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 20V, NegativeNot Available Predicted LC-MS/MS

    Predicted LC-MS/MS Spectrum – 40V, NegativeNot Available

    Biological Properties Cellliar Locations

  • Extracellliar
  • Biofluid Locations

  • Bile
  • Blood
  • Feces
  • Urine
  • Tissue Location

  • Prostate
  • Pathways

    Name SMPDB Link KEGG Link 27-Hydroxylase DeficiencySMP00720Not Available Bile Acid BiosynthesisSMP00035map00120 Cerebrotendinous Xanthomatosis (CTX)SMP00315Not Available Congenital Bile Acid Synthesis Defect Type IISMP00314Not Available Congenital Bile Acid Synthesis Defect Type IIISMP00318Not Available Familial Hypercholanemia (FHCA)SMP00317Not Available Zellweger SyndromeSMP00316Not Available

    Normal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details BileDetected and Quantified>0.01 uMAdlit (>18 years old)BothNormal

  • 659989
  • details BloodDetected and Quantified0.06 +/- 0.01 uMAdlit (>18 years old)BothNormal

  • Geigy Scientific …
  • Basel, Switzerlan…
  • West Cadwell, N.J…
  • details FecesDetected but not Quantified Adlit (>18 years old)BothNormal

  • 19636438
  • details FecesDetected but not Quantified Children (1-13 years old)BothNormal

  • 19636438
  • details FecesDetected and Quantified22.28 +/- 15.65 nmol/g of fecesNot SpecifiedNot Specified

    Normal

  • 22664055
  • details UrineDetected and Quantified0.0013 +/- 0.0026 umol/mmol creatinineInfant (0-1 year old)BothNormal

  • 3944741
  • details

    Abnormal Concentrations

    Biofluid Status Value Age Sex Condition Reference Details FecesDetected but not Quantified Adlit (>18 years old)BothCCD

  • 19636438
  • details FecesDetected but not Quantified Adlit (>18 years old)BothICD

  • 19636438
  • details FecesDetected but not Quantified Not SpecifiedNot Specified

    Recurrent Clostridium difficile infection

  • 24284963
  • details FecesDetected but not Quantified Not SpecifiedNot Specified

    Recurrent Clostridium difficile infection

  • 24284963
  • details UrineDetected and Quantified0.032 +/- 0.058 umol/mmol creatinineAdlit (>18 years old)BothBiliary atresia

  • 3944741
  • details

    Associated Disorders and Diseases Disease References

    Biliary atresia

    1. Nittono H, Obinata K, Nakatsu N, Watanabe T, Niijima S, Sasaki H, Arisaka O, Kato H, Yabuta K, Miyano T: Slifated and nonslifated bile acids in urine of patients with biliary atresia: analysis of bile acids by high-performance liquid chromatography. J Pediatr Gastroenterol Nutr. 1986 Jan;5(1):23-9. [PubMed:3944741 ]

    Associated OMIM IDs

  • 210500 (Biliary atresia)
  • External Links DrugBank ID

    Not Available DrugBank Metabolite ID

    Not Available Phenol Explorer Compound ID

    Not Available Phenol Explorer Metabolite ID

    Not Available FoodDB ID

    FDB022157 KNApSAcK ID

    Not Available Chemspider ID

    17215984 KEGG Compound ID

    C05466 BioCyc ID

    Not Available BiGG ID

    45866 Wikipedia Link

    Not Available NuGOwiki Link

    HMDB00637 Metagene Link

    HMDB00637 METLIN ID

    5610 PubChem Compound

    22833540 PDB ID

    1FMC ChEBI ID

    Not Available

    Product: Lasalocid (sodium)

    References Synthesis Reference Parmentier G; Eyssen H Synthesis and characteristics of the specific monosulfates of chenodeoxycholate, deoxycholate and their taurine or glycine conjugates. Steroids (1977), 30(5), 583-90. Material Safety Data Sheet (MSDS) Not Available General References
    1. Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
    2. Hepner GW, Demers LM: Dynamics of the enterohepatic circulation of the glycine conjugates of cholic, chenodeoxycholic, deoxycholic, and sulfolithocholic acid in man. Gastroenterology. 1977 Mar;72(3):499-501. [PubMed:832799 ]
    3. Bloch CA, Watkins JB: Determination of conjugated bile acids in human bile and duodenal fluid by reverse-phase high-performance liquid chromatography. J Lipid Res. 1978 May;19(4):510-3. [PubMed:659989 ]
    4. Demers LM, Hepner G: Radioimmunoassay of bile acids in serum. Clin Chem. 1976 May;22(5):602-6. [PubMed:1261008 ]
    5. Makino I, Shinozaki K, Nakagawa S, Mashimo K: Measurement of sulfated and nonsulfated bile acids in human serum and urine. J Lipid Res. 1974 Mar;15(2):132-8. [PubMed:4832755 ]
    6. Goto T, Myint KT, Sato K, Wada O, Kakiyama G, Iida T, Hishinuma T, Mano N, Goto J: LC/ESI-tandem mass spectrometric determination of bile acid 3-sulfates in human urine 3beta-Sulfooxy-12alpha-hydroxy-5beta-cholanoic acid is an abundant nonamidated sulfate. J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Feb 1;846(1-2):69-77. Epub 2006 Sep 1. [PubMed:16949895 ]

    Enzymes

    General function:
    Involved in thiolester hydrolase activity
    Specific function:
    Involved in bile acid metabolism. In liver hepatocytes catalyzes the second step in the conjugation of C24 bile acids (choloneates) to glycine and taurine before excretion into bile canaliculi. The major components of bile are cholic acid and chenodeoxycholic acid. In a first step the bile acids are converted to an acyl-CoA thioester, either in peroxisomes (primary bile acids deriving from the cholesterol pathway), or cytoplasmic at the endoplasmic reticulum (secondary bile acids). May catalyze the conjugation of primary or secondary bile acids, or both. The conjugation increases the detergent properties of bile acids in the intestine, which facilitates lipid and fat-soluble vitamin absorption. In turn, bile acids are deconjugated by bacteria in the intestine and are recycled back to the liver for reconjugation (secondary bile acids). May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids. In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs.
    Gene Name:
    BAAT
    Uniprot ID:
    Q14032
    Molecular weight:
    46298.865
    Reactions
    Chenodeoxycholoyl-CoA + Glycine → Chenodeoxycholic acid glycine conjugate + Coenzyme A details
    General function:
    Involved in glycine N-acyltransferase activity
    Specific function:
    Mitochondrial acyltransferase which transfers an acyl group to the N-terminus of glycine and glutamine, although much less efficiently. Can conjugate numerous substrates to form a variety of N-acylglycines, with a preference for benzoyl-CoA over phenylacetyl-CoA as acyl donors. Thereby detoxify xenobiotics, such as benzoic acid or salicylic acid, and endogenous organic acids, such as isovaleric acid.
    Gene Name:
    GLYAT
    Uniprot ID:
    Q6IB77
    Molecular weight:
    18506.33
    General function:
    Involved in glycine N-acyltransferase activity
    Specific function:
    Acyltransferase which transfers an acyl group to the N-terminus of glutamine. Can use phenylacetyl-CoA as an acyl donor.
    Gene Name:
    GLYATL1
    Uniprot ID:
    Q969I3
    Molecular weight:
    35100.895
    General function:
    Involved in glycine N-acyltransferase activity
    Specific function:
    Mitochondrial acyltransferase which transfers the acyl group to the N-terminus of glycine. Conjugates numerous substrates, such as arachidonoyl-CoA and saturated medium and long-chain acyl-CoAs ranging from chain-length C8:0-CoA to C18:0-CoA, to form a variety of N-acylglycines. Shows a preference for monounsaturated fatty acid oleoyl-CoA (C18:1-CoA) as an acyl donor. Does not exhibit any activity toward C22:6-CoA and chenodeoxycholoyl-CoA, nor toward serine or alanine.
    Gene Name:
    GLYATL2
    Uniprot ID:
    Q8WU03
    Molecular weight:
    34277.055
    General function:
    Involved in glycine N-acyltransferase activity
    Specific function:
    Acyltransferase which transfers the acyl group to the N- terminus of glycine
    Gene Name:
    GLYATL3
    Uniprot ID:
    Q5SZD4
    Molecular weight:
    32703.3

    PMID: 7626110